Atlas Trials

Covid-19 Associated Coagulopathy Predicted by Thrombodynamic Markers (CoViTro-I)

Clinical trial NCT05330832 · UNKNOWN

Trial details

NCT number
NCT05330832
Sponsor
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Status
UNKNOWN
Study type
OBSERVATIONAL
Coronavirus Disease 2019
Start date
2020-04-01
Primary completion
2020-12-15
Enrollment
2200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.